Clinical trial
Targeted Melanoma Detection With Skin Self-Examination During COVID-19…
NCT04420273 · Northwestern University, Other · Completed
Key facts
| NCT number | NCT04420273 |
|---|---|
| Title | Targeted Melanoma Detection With Skin Self-Examination During COVID-19 Restricted Physician Access |
| Official title | Targeted Melanoma Detection With Skin Self-examination: Leveraging the Mammogram Encounter |
| Acronym | TMD |
| Lead sponsor | Northwestern University, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Melanoma |
| Intervention type | Behavioral |
| Interventions | SSE educational intervention, Active control:Healthy Living |
| Enrollment | 1,000 |
| Start date | Jul 2, 2020 |
| Primary completion | Mar 1, 2021 |
| Completion | Mar 1, 2021 |
| First posted | Jun 9, 2020 |
| Last update posted | Nov 23, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: